Willow Neuroscience, Inc. — Form D/A
Willow Neuroscience, Inc. of Palo Alto, CA, a company, filed a Form D amendment with the SEC on 2023-07-10. The offering totals $3.3M, of which $2.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-07-10
- Form: D/A
- Accession: 0001812857-23-000005
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.3M
- Amount sold: $2.1M
- Remaining: $1.2M
- Investors: 19
- Date of first sale: 2016-01-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-429648
Issuer
- Name: Willow Neuroscience, Inc.
- CIK: 0001701524
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: c/o Alexandria Launch Labs, Palo Alto, CA, 94304
- Phone: 510-588-8840
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Katrin I Andreasson | Director | Palo Alto, CA |
| Mark P de Souza | Director | Emeryville, CA |
| Michelle L James | Director | Palo Alto, CA |
| Mark P de Souza | Executive Officer | Emeryville, CA |
| John I Kincaid | Director | Emeryville, CA |
| John I Kincaid | Executive Officer | Emeryville, CA |
| Michael C Venuti | Executive Officer | Emeryville, CA |
Other filings by this issuer (2)
More